IFITM2 promotes gastric cancer progression by promoting cell migration and invasion, and inducing EMT (Xu et al., 2017), and interacts with the SARS-CoV-2 S at the cell surface and virus-cell fusion in early endosomes (Prelli Bozzo et al., 2021). Here, IFITM2 is linked to gastric cancer.